Pfizer to acquire Seagen for USD 43bn
The deal could close in late 2023 or early 2024 after being cleared by stakeholders and authorities.
by ulrich quistgaard, translated by daniel pedersen
Seagen and Pfizer have reached an acquisition agreement under which Pfizer will pay USD 229 per Seagen share for a total price of around USD 43bn.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Pfizer to acquire Seagen, says media
For subscribers
Three Genmab cancer drugs close in on big milestones in 2023
For subscribers
Pfizer's migraine nasal spray gets FDA nod
For subscribers
.jpg&w=384&q=75)
